Type 2 diabetes care in the Philippines, from the first risk check to the specialist.
CareGenicsAI is a digital health platform being built for Filipino patients, families and doctors. It will connect risk screening, personal guidance, monitoring and eye-care referral. Your doctor stays in charge of your care.
Public launch
Add 12 November 2027 to your calendar
Before then, a pilot is planned in Cabanatuan City, Nueva Ecija.
Join the waitlist
We will email you about the pilot and the public launch, and about user research only if you agree. You can unsubscribe at any time.
Many people in the Philippines learn they have diabetes only when complications start.
Screening and follow-up are inconsistent outside the big cities, and diabetologists and eye specialists are hard to reach in the provinces. Many people find out they have diabetes only when complications have already started.
One pathway, in four steps
These are the parts of the platform we are building now. They are in development and not yet available.
Step 1
Risk check
Will estimate Type 2 diabetes risk using lab data and Filipino demographic factors, so people who may need testing can talk to a doctor sooner.
Step 2
Personal guidance
Will suggest changes to food, activity and daily habits based on each person's results.
Step 3
Monitoring between visits
Will track blood sugar control and other health readings over time, and share them with the patient's care team.
Step 4
Eye-care referral
Will include a screening pathway for diabetic retinopathy, with referral to eye specialists.
Doctors stay in charge. CareGenicsAI is designed to support clinical care. Diagnosis and treatment decisions stay with each patient's doctor.
Made for how care works in the Philippines
In the languages people use
The platform is being designed to be multilingual and culturally adapted for Filipino users.
When the signal is weak
SMS and offline features are planned for places with unreliable internet.
Free to start for individuals
Core tracking features are planned to be free for individuals. Optional paid features may include personalized nutrition plans and consultations with sub-specialists.
Who CareGenicsAI is for
People at risk, patients and families
Will offer risk checks, guidance and reminders on their phone. Core tracking is planned to be free.
Clinics and laboratories
Will offer a subscription for patient monitoring dashboards and tools that support clinical decisions.
LGUs, HMOs and insurers
Will offer population health analysis and risk grouping to help decide where resources should go.
Where we are and what comes next
- So farDone
Capstone and prototype
CareGenicsAI received a Clean Pass as an EMBA capstone project, and the prototype is in development.
- Q4 2026Planned
Pilot in Cabanatuan City
A pilot with 500 patients in Cabanatuan City, Nueva Ecija.
- 12 Nov 2027Planned
Public launch
CareGenicsAI opens to the public.
- Q4 2027Target
20 hospitals, 2,000+ active users
Expansion to 20 hospitals and more than 2,000 active users.
- 2028 onwardGoal
National reach
Work toward integration with national health insurance and public health programs.
The people building CareGenicsAI
A nine-person founding and advisory team with experience in analytics, diabetology, ophthalmology, nutrition, cybersecurity, enterprise architecture and data science.
Clinical team
Dra. Cristy Samin
Chief Medical Officer, Nutrition Science
Dra. Sheryl Yang
Medical Advisor, Diabetology
Dra. Cel Arenal
Medical Advisor, Retina Specialist
Dr. Alex Tiongson
Medical Advisor, Neurology and Ophthalmology
Dr. Paul Simbulan
Medical Advisor, Neurosurgical Specialist
Technology, security and operations
Melvin Ferrer
Founder and Analytics, EMBA, BI Strategy, Data Governance
Khadija Cajayon
Cybersecurity, RN, MBA, MS Cybersecurity
Joseph Buluran
Technology Advisor, Enterprise Architecture and Engineering
Divina Egango
Operations Advisor, Data Science and Operations
Common questions
What is CareGenicsAI?
A digital health platform for Type 2 diabetes, being built for the Philippines. It will combine risk checks, personal guidance, monitoring and a referral pathway for diabetic eye disease.
Can I use it now?
Not yet. The public launch is planned for 12 November 2027. Before then, a pilot is planned in Cabanatuan City. Join the waitlist and we will email you with pilot updates and before the public launch.
Does CareGenicsAI diagnose diabetes?
No. It is being designed to estimate risk and to support your doctor's care. Only a doctor can diagnose diabetes and decide on treatment.
Will it work without internet?
SMS and offline features are planned for places with weak or no internet connection.
What languages will it use?
It is being designed to be multilingual. We will confirm the languages before launch.
How much will it cost?
Prices are not set yet. Our plan is to keep core tracking features free for individuals, with optional paid features.
What do you do with my information?
For the waitlist we only ask for your email, how you are interested and, if you choose, your region. We use it to send updates about the pilot and the launch, and to invite you to user research only if you agree. We handle it under the Data Privacy Act of 2012.
I work for a clinic, hospital, LGU or HMO. How can we work together?
Tell us about your organization on the partnerships page and we will get back to you.
Who is behind CareGenicsAI?
A team of nine, including a founder in analytics, a chief medical officer in clinical nutrition, medical advisors in diabetology, retina and neurology, and advisors in technology and operations.
Sources
- 1International Diabetes Federation. IDF Diabetes Atlas, 11th edition (2025). Philippines diabetes country report 2000–2050. diabetesatlas.org/data-by-location/country/philippines/